TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Sulforaphane, Acetazolamide
Phytochemical Name Sulforaphane (PubChem CID: 5350 )
Anticancer drug Name Acetazolamide (PubChem CID: 1986 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 908
Pair Name Sulforaphane, Acetazolamide
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Gene Regulation Down-regulation Expression NANOGNB hsa360030
Down-regulation Expression POU5F1 hsa5460
Down-regulation Expression SOX2 hsa6657
In Vitro Model NCI-H727 Lung carcinoid tumor Homo sapiens (Human) CVCL_1584
NCI-H720 Lung carcinoid tumor Homo sapiens (Human) CVCL_1583
In Vivo Model H727 and H720 parental and 3rd generation spheroid cells (3×10⁴) were injected into the subcutaneous inguinal fat pad of NOD/SCID mice.
Result Human bronchial carcinoid tumor cells serially passaged as spheroids contain a higher fraction of TIC exhibiting a stemness phenotype. This TIC population can be effectively targeted by the combination of AZ + SFN. Our work portends clinical relevance and supports the therapeutic use of the novel AZ+ SFN combination that may target the TIC population of bronchial carcinoids.
03. Reference
No. Title Href
1 Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane. BMC Cancer. 2019 Aug 30;19(1):864. doi: 10.1186/s12885-019-6018-1. Click
It has been 48736 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP